Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02262910
Title Study of MOR209/ES414 in Metastatic Castration-Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Aptevo Therapeutics
Indications
Therapies
Age Groups: adult | senior | child
Covered Countries USA | AUS

Facility Status City State Zip Country Details
University of California San Francisco California 94143 United States Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
Central Texas Veterans Health Care System Temple Texas 76504 United States Details
University of Washington/Seattle Cancer Care Alliance Seattle Washington 98109 United States Details
St. Vincent's Hospital Sydney Darlinghurst New South Wales 2010 Australia Details
Monash Medical Centre Clayton Victoria 3168 Australia Details
Peter MacCallum Cancer Centre East Melbourne Victoria 3002 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field